4.7 Article

Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

Daniel B. Larremore et al.

Summary: The COVID-19 pandemic has led to a public health crisis due to the spread of SARS-CoV-2 through presymptomatic, symptomatic, and asymptomatic individuals. Effective population screening for the virus is essential for reopening societies and controlling its spread, with testing frequency and reporting speed playing crucial roles in its success. Test sensitivity is only marginally important compared to these factors.

SCIENCE ADVANCES (2021)

Letter Biochemistry & Molecular Biology

'Test, re-test, re-test': using inaccurate tests to greatly increase the accuracy of COVID-19 testing

Kamalini Ramdas et al.

NATURE MEDICINE (2020)

Article Statistics & Probability

Bayesian analysis of tests with unknown specificity and sensitivity

Andrew Gelman et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2020)

Article Obstetrics & Gynecology

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Rebecca B. Perkins et al.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)

Article Immunology

Rotavirus, vaccine failure or diagnostic error?

Monica Lopez-Lacort et al.

VACCINE (2016)

Article Public, Environmental & Occupational Health

How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null?

Anne M. Jurek et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)